Authors


Prince Prabhakar, MD

Latest:

A New CME: Continuing Moral Education

Every phase of the COVID-19 pandemic brings new ethical challenges.


Claire Cohen, MD

Latest:

10 Measures and Outcomes to Assess Progress in Eradicating Racism

Suggestions to assess outcomes and measure success levels in combatting racism.



Dania Albaba, MD

Latest:

The Confluence of Human Trafficking, Drug Trafficking, Militias, and Substance Use

Explore the devastating impact of substance abuse, human trafficking, and conflict on individuals and communities.


Jacqueline Landess, MD, JD

Latest:

Abortion and the Psychiatrist: Practicing in Post-Dobbs America

"The psychiatrist may be obligated to protect the fetus or warn authorities of the patient’s intent."


Mindy Oshrain, MD

Latest:

Including Racism in a Trauma History: A Clinician’s Reflections

Psychiatry has changed, and we now have an acute awareness of the cost of sexual trauma to patients. When it comes to race, however, we still have a lot to learn.


Caleb Natale

Latest:

Sex, Drugs, and Psychosis: Reviewing Psychiatric Medications’ Taboo Side Effect

The sexual side effects of psychiatric medications are troubling enough that some patients consider treatment cessation. The authors review 5 strategies for managing sexual dysfunction.


Craig J. Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP

Latest:

The Cardiovascular Consequences of Drug Use

Some commonly used drugs and narcotics have serious cardiovascular effects.


Anosha Zanjani, MSc, MArch

Latest:

Mental Health Stigma for Providers: A Hidden Challenge Among Us

Stigma poses a serious risk to quality of care and accessibility.


Kultaj Kaleka MD, RN

Latest:

How Do We Grieve?

A resident reflects on the clinician experience of loss and grief, and how these emotions can help decrease the distance between clinicians and patients.


Grethel Perez Meek, DO

Latest:

Phase 3 Trials Examine Gantenerumab for Early Alzheimer Disease

Two phase 3 trials were conducted to assess the clinical and biological effects as well as the safety of gantenerumab in individuals with mild cognitive impairment or mild dementia due to AD. Here's what you need to know.


Mary V. Seeman, MD

Latest:

Developing Effective Treatment Strategies for Women With Schizophrenia

The presentation of schizophrenia differs significantly between men and women. Here's what you need to know.


Laura Erickson-Schroth, MD, MA

Latest:

Helping LGBTQ Youth During the Pandemic

Overwhelmed and encumbered agencies are increasingly unable to provide critical services for LGBTQ youth, leaving them powerless in impeding a downward spiral into homelessness and associated negative ramifications. There are 5 ways psychiatrists can help.


Manish Sapra, MD, MMM, FAPA

Latest:

4 Questions About Burnout

An expert discusses the common causes of burnout, as well as what both organizations and clinicians can do to support clinician well-being.



Michael Okun, MD

Latest:

Mental Health Tips for Living with Parkinson Disease

The largest unmet hurdle in dealing with Parkinson disease is the treatment of depression.


Tony Morrison, DClinPsy

Latest:

A Dialogue on Psychosis and Trauma

Joining together to discuss psychosis, 3 British experts discuss various ways to respond to and help people who have experienced both trauma and psychosis.


Philippa Garety, MPhil, PhD

Latest:

Psychiatry’s Problem With Paranoia—Is Digital Part of the Solution?

A new digital therapeutic helps patients with psychosis to slow down and manage their fears.


Freya Shepherd, MSc, BSc

Latest:

An Update on the Presentation, Nosology, and Causes of Postpartum Psychosis

Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.


Tae Hwan Chung, MD

Latest:

Mysterious Post-COVID Symptoms Aren't All in Your Patients’ Heads

How to recognize postural orthostatic tachycardia syndrome—and treat it.


Jeffrey Khan, MD

Latest:

Too Tired for More: How Best to Treat Multifactorial Fatigue

Fatigue: a very common physical complaint that often accompanies depressive disorders.


Boris Rubinstein, MD, MPH

Latest:

Black Lives Matter: My Jewish Perspective

One psychiatrist offers his thoughts on anti-black racism through the lens of anti-Semitism.


Lauren Biscaldi

Latest:

Mixed Bag Phase 3 Data for ADHD Treatment Presented at ASHP Meeting

Data showed good news for safety and tolerability with mixed good news for efficacy.


Sripriya Chari, PhD

Latest:

Clinical Pearls: Treating Trauma and Psychosis

Learn more about best practices when treating comorbid trauma and psychosis.


Theodore Edmonds, JD

Latest:

Building Brain Resilience: A Multi-Level Systems Approach

Beyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.


Manzoor Elahi, MD

Latest:

Adult Attention-deficit/Hyperactivity Disorder (aADHD)

Although normally associated with children, attention-deficit/hyperactivity disorder can also persist in adulthood, presenting challenges to both patients and clinicians.


Richard E. Rhoden, MD

Latest:

ADHD Across the Lifespan

ADHD in adults lead to educational, occupational, relational, and judgment impairments.


William H. Reid, MD, MPH

Latest:

Writing for General Readers

“Most people say that pretty much all physicians have a book inside them—and I agree.”


Daniella Spencer-Laitt, MA

Latest:

Treating Prolonged Grief Disorder: Innovations and Future Directions

What is the best treatment course for prolonged grief disorder?


Dustin Nowaskie, MD

Latest:

Psychiatrists Call for End to Cruel and Harmful Immigration Policy

The Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.

© 2025 MJH Life Sciences

All rights reserved.